Sorry, we do not have enough data to show an influence graph for this author.
- Full text PDF available (0)
Journals and Conferences
Ziprasidone is a neuroleptic drug recently sold in Spain. According to its profile of receptors it is considered an atypical or second generation antipsychotic agent. Its use has been associated to increase of the QT interval, which might trigger potentially lethal ventricular arrhythmia. We present a case of overdose with moderate doses of the drug, in… (More)